By one measure, there has been as much as a 4000% year-over-year boost in telehealth utilization. Despite this, obstacles remain on the path to virtual care's emergence as a central pillar of the care delivery system. Providers have expressed concerns about quality of care and patients are unsettled by data privacy issues—and for good reason: cyberattacks on telehealth companies have surged.
As COVID-19 has exposed risks (and created new fears) associated with long-term care facilities, the vast majority of Baby Boomers are hoping to age in the comfort of their home. In a call to entrepreneurs and investors, our latest piece highlights eight areas of opportunity for tech-supported aging in place innovation.
On the heels of the Teladongo deal, more exits abound. Amwell and GoodRx have filed to go public, each with a somewhat surprising trajectory: Amwell with a $100M investment from Google Cloud and GoodRx with a track record of profits. Meanwhile, Amazon has moved into the wearable market with its Halo tracker, taking on juggernauts Apple and Fitbit.
Even before the pandemic, an increasing number of consumers were turning to Dr. Google—a trend that underscores the tech giant’s strategy to reinvent how people access health information. With virtual care offering greater convenience, CVS’s Chief Digital Officer is betting the shift to telemedicine will continue. We reflected on this trend and identified five ways health systems can build or refine their digital front door strategy. And we’re putting our money where our mouth is: Rock Health is proud to announce our latest investment in Brightline’s $20M round, as they expand virtual pediatric behavioral health services to families across California (and more states coming soon)!
As the nation’s mental health crisis surges, digital behavioral health solutions are poised for takeoff. Yet some argue there’s reason to be wary—concerns around clinical validation and patient privacy are emerging. Evidence generation is more important now than ever. Check out how Omada and Evidation are partnering to measure outcomes in everyday life and creating the gold standard of decentralized clinical trials on the Rock Health Podcast.
In an explosive $18.5B megadeal, Teladoc announced its merger with Livongo to become the “greatest virtual care platform in the market.” This announcement is merely the starter pistol for a virtual care platforms race—we anticipate a chain reaction of M&A among telemedicine companies looking to build more comprehensive healthcare solutions. There’s more on the exit horizon—GoodRx filed for an IPO and PE firm Blackstone acquired a majority share of Ancestry for $4.7B.
We’re just at the tip of the iceberg when it comes to transforming the health of all women. Just 3% of all digital health funding since 2011 has focused on women’s health—65% of which has gone to supporting fertility and pregnancy/motherhood. But the Femtech opportunity extends much further—we see an untapped market capable of supporting the diversity of women’s experiences, with an emphasis on addressing health inequities and tackling stigmatized conditions.
As COVID-19 cases surge, data continues to be key—and contentious—in fighting the pandemic. Following last week’s directive for hospitals to bypass the CDC when reporting coronavirus stats, HHS unveiled a new Coronavirus Data Hub—but hospitals are scrambling to pivot.
The nation’s largest insurer has entered the digital diabetes management scene. As the industry sways between build versus buy, UnitedHealth Group debuted its home-grown type 2 diabetes platform. Meanwhile, online health insurance marketplace GoHealth made its public market debut to the tune of $914M.
In the shadow of the pandemic, a number of players are looking to make waves in the $260B primary care market. Walgreens is taking the plunge—with a $1B investment in VillageMD, the retail pharmacy giant plans to open as many as 700 doctors’ offices in its stores.